On June 9, Centene rose 5.03% in regular trading, trading at $65.457/share, with trading volume of $288 million. The rally comes amid a wave of analyst target price upgrades over recent sessions.
JPMorgan raised its target price on Centene from $52 to $60 on June 8 while maintaining a Neutral rating. Earlier, Truist lifted its target from $58 to $71 on June 1 with a Buy rating, and Morgan Stanley raised its target from $50 to $57 on June 4, maintaining an Equal Weight rating. The consensus mean target price among analysts polled stands at approximately $60, with an average Overweight rating.
Within the Managed Health Care sector, peer stocks also showed broad strength. Among individual stocks, Molina Healthcare up 3.67%, UnitedHealth up 1.78%, Humana up 1.04%, Elevance Health up 0.29%, while HealthEquity down 0.37%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)